trovafloxacin has been researched along with Acute Disease in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (62.50) | 18.2507 |
| 2000's | 3 (37.50) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arvis, P; Klossek, JM; Leberre, MA; Nikolaidis, P; Siegert, R | 1 |
| Araujo, FG; Khan, AA; Polzer, RJ; Remington, JS; Slifer, T | 1 |
| Baldwin, RJ; Léophonte, P; Pluck, N | 1 |
| Daniel, R; O'Doherty, B | 1 |
| Hopkins, S; Williams, D | 1 |
| Chatwani, A; Dittrich, R; Koltun, W; Luke, DR; Martens, MG; Roy, S | 1 |
| Alcantára, R; Alvarez, A; Andrade, RJ; Camargo, R; Lopez-Garrido, MJ; Lucena, MI; Rodrigo, L; Salmerón, J | 1 |
| Carbon, C; Chau, F; Dautrey, S; Faurisson, F; Join-Lambert, OF; Köhler, T; Michéa-Hamzehpour, M; Pechère, J; Vissuzaine, C | 1 |
5 trial(s) available for trovafloxacin and Acute Disease
| Article | Year |
|---|---|
Comparison of the efficacy and safety of moxifloxacin and trovafloxacin for the treatment of acute, bacterial maxillary sinusitis in adults.
Topics: Acute Disease; Adult; Anti-Infective Agents; Aza Compounds; Bacterial Infections; Dose-Response Relationship, Drug; Double-Blind Method; Female; Fluoroquinolones; Humans; Male; Maxillary Sinusitis; Microbial Sensitivity Tests; Middle Aged; Moxifloxacin; Naphthyridines; Prospective Studies; Quinolines; Treatment Outcome | 2003 |
Trovafloxacin versus amoxicillin/clavulanic acid in the treatment of acute exacerbations of chronic obstructive bronchitis.
Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Anti-Infective Agents; Bronchitis; Chlamydia Infections; Chronic Disease; Drug Therapy, Combination; Female; Fluoroquinolones; Haemophilus Infections; Humans; Male; Middle Aged; Naphthyridines; Pneumococcal Infections | 1998 |
Treatment of acute exacerbations of chronic bronchitis: comparison of trovafloxacin and amoxicillin in a multicentre, double-blind, double-dummy study. Trovafloxacin Bronchitis Study Group.
Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Infective Agents; Bronchitis; Chronic Disease; Double-Blind Method; Drug Administration Schedule; Female; Fluoroquinolones; Haemophilus Infections; Haemophilus influenzae; Humans; Male; Middle Aged; Naphthyridines; Penicillins | 1998 |
Safety of trovafloxacin in treatment of lower respiratory tract infections.
Topics: Acute Disease; Aged; Anti-Infective Agents; Bronchitis; Cardiovascular System; Chronic Disease; Community-Acquired Infections; Digestive System; Double-Blind Method; Europe; Fluoroquinolones; Humans; Naphthyridines; Nervous System; Pneumonia, Bacterial | 1998 |
Treatment of acute gynecologic infections with trovafloxacin. Trovafloxacin Surgical Group.
Topics: Acute Disease; Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Cefoxitin; Cephamycins; Clavulanic Acid; Double-Blind Method; Enterococcus; Female; Fluoroquinolones; Humans; Middle Aged; Naphthyridines; Pelvic Inflammatory Disease; Penicillins; Prospective Studies; Treatment Outcome | 1998 |
3 other study(ies) available for trovafloxacin and Acute Disease
| Article | Year |
|---|---|
Activity of trovafloxacin in combination with other drugs for treatment of acute murine toxoplasmosis.
Topics: Acute Disease; Administration, Oral; Animals; Anti-Infective Agents; Antiprotozoal Agents; Area Under Curve; Atovaquone; Clarithromycin; Drug Synergism; Drug Therapy, Combination; Female; Fluoroquinolones; Mice; Naphthoquinones; Naphthyridines; Rifabutin; Tissue Distribution; Toxoplasmosis, Animal | 1997 |
Trovafloxacin-induced acute hepatitis.
Topics: Acute Disease; Adult; Aged; Anti-Infective Agents; Biopsy, Needle; Chemical and Drug Induced Liver Injury; Fluoroquinolones; Humans; Liver Function Tests; Male; Middle Aged; Naphthyridines; Pneumonia, Pneumococcal; Prognosis; Respiratory Tract Infections | 2000 |
Differential selection of multidrug efflux mutants by trovafloxacin and ciprofloxacin in an experimental model of Pseudomonas aeruginosa acute pneumonia in rats.
Topics: Acute Disease; Animals; Anti-Infective Agents; Ciprofloxacin; Drug Resistance, Microbial; Drug Resistance, Multiple; Fluoroquinolones; Lung; Male; Mutation; Naphthyridines; Pneumonia, Bacterial; Pseudomonas aeruginosa; Rats; Rats, Sprague-Dawley | 2001 |